or it had a different mechanism of action. “There’s a lot of hype and excitement around GLP-1 and like medications,” Youssef. “And the thing I want to see is long-term safety data.

[1] In the presence of elevated glucose concentrations, GLP-1 and GIP ... beyond its proteolytic action, including T-cell activation and proliferation. Although the mechanism of action may ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.

Those indications has helped drive quarterly sales of the drug above the $1 billion threshold ... although with different mechanisms of action there is potential for combination use.

The new agreement comes just days after AZ closed a $3.1 billion licensing agreement ... of amyloidosis that may require multiple mechanisms of action to address those needs," said AZ in a ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

As a result, "the exact mechanism of the way these medications work is not fully established," he says. This isn’t the first study to find a link between taking GLP-1 drug and drinking less.

GLP-1 therapies have demonstrated significant cardiometabolic benefits, particularly in high-risk patients with cardiovascular disease. Recent trials have shown the effectiveness of GLP-1 ...

pulling on the waistband of jeans that no longer fit, showing her transformation. The demand for GLP-1 (glucagon-like peptide-1) medicines like Ozempic, Wegovy, and Mounjaro is disrupting the ...